Results 171 to 180 of about 4,117 (197)

Prurigo Nodularis

Proceedings of the Royal Society of Medicine, 1934
J E, Wigley, G, Heggs
openaire   +2 more sources

Treatment of Prurigo Nodularis With Thalidomide

Archives of Dermatology, 1980
A 57-year-old man with prurigo nodularis, was unresponsive to conventional therapy, was successfully treated with thalidomide. The pharmacology and side effects of the drug are briefly reviewed. Why thalidomide is effective for prurigo nodularis is unclear, but possible mechanisms of action are discussed.
openaire   +2 more sources

Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response

Journal of Dermatological Treatment, 2022
Husein Husein-Elahmed, Martin Steinhoff
exaly  

Therapeutic potential of biologics in prurigo nodularis

Expert Opinion on Biological Therapy, 2022
Thomas Bieber, Sonja Ständer, Svenja Müller   +2 more
exaly  

Prurigo Nodularis

2016
Hugh Morris Gloster, Lauren E. Gebauer, Rachel L. Mistur   +2 more
  +4 more sources

Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis

Expert Review of Clinical Pharmacology, 2021
Pegah Bakhshi, Nishadh Sutaria, Justin Choi   +2 more
exaly  

Prurigo nodularis

Der Hautarzt, 2014
S. Ständer, T. Mettang
openaire   +1 more source

Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study

EClinicalMedicine, 2023
Howard Sofen
exaly  

Health-related quality of life and economic burden of prurigo nodularis

Journal of the American Academy of Dermatology, 2022
Nishadh Sutaria, Yevgeniy Semenov, Raveena Khanna   +2 more
exaly  

Dupilumab as promising treatment for prurigo nodularis: current evidences

Journal of Dermatological Treatment, 2022
Claudio Conforti, Caterina Dianzani, Enrico Zelin   +2 more
exaly